Chirfi Guindo

EVP, Access, Policy & Comms

Chirfi Guindo (EVP, Access, Policy & Comms) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Merck & Co., Inc. (MRK). The largest single filing was $2.4M of MRK (20,000 sh × $121.88, as filed), executed Feb 5.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 5 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$8.2M

shares × price, as filed

Last traded

Aug 13

Filed Aug 13

Median ADV $1.4B across their filed names

Open performance→

Volume by month

Buys $0 Sells $8.2M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 5 filings

Sector per market data · by filing · past 12 months

Most traded names

MRK

Merck & Co., Inc. MRK · 0 buys · 5 sells 5 filings

Recent filings

MRKSALE Merck & Co., Inc. View filing → $1.4M
10,000 sh × $135.00
Exec Aug 13
Filed Aug 13 · 5:02 PM ET MRKSALE Merck & Co., Inc. View filing → $2.0M
15,000 sh × $131.00
Exec Aug 6
Filed Aug 7 · 4:17 PM ET MRKSALE Merck & Co., Inc. View filing → $1.2M
10,000 sh × $121.46
Exec Feb 12
Filed Feb 12 · 5:30 PM ET MRKSALE Merck & Co., Inc. View filing → $1.2M
10,000 sh × $118.41
Exec Feb 9
Filed Feb 9 · 5:30 PM ET MRKSALE Merck & Co., Inc. View filing → $2.4M
20,000 sh × $121.88
Exec Feb 5
Filed Feb 6 · 5:30 PM ET